Please login to the form below

Not currently logged in
Email:
Password:

Benepali

This page shows the latest Benepali news and features for those working in and with pharma, biotech and healthcare.

First Humira biosimilars reach EU market

First Humira biosimilars reach EU market

Samsung Bioepis already has two other biosimilar TNF inhibitors available in Europe - Benepali (etanercept) and Flixabi (infliximab) – giving it an opportunity to quickly leverage its established sales channels in rolling out

Latest news

More from news
Approximately 2 fully matching, plus 12 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 2 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Consulting at McCann Health

We are the strategic consultancy of McCann Health. We combine fresh and creative thinking with scientific and strategic depth...

Latest intelligence

China’s clinical trial shake-up
As many of the obstacles to running clinical trials in China fall away, the country is proving to be a better research location...
Alzheimer’s disease – is Europe prepared if a breakthrough treatment becomes available?
Healthcare leaders in the European Union should begin preparing for a breakthrough now...
The UK’s new five-year pricing agreement
Pharma has agreed to capped growth again - in exchange for uptake promises...

Infographics